Your activity: 9704 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: [email protected]

Microbiology and pathogenesis of Yersinia infections

Microbiology and pathogenesis of Yersinia infections
Author:
Robert V Tauxe, MD, MPH
Section Editor:
Stephen B Calderwood, MD
Deputy Editor:
Elinor L Baron, MD, DTMH
Literature review current through: Feb 2022. | This topic last updated: Sep 23, 2021.

INTRODUCTION — The genus Yersinia includes 18 species, three of which are important human pathogens: Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis [1,2]. The yersinioses are zoonotic infections of domestic and wild animals; humans are considered incidental hosts that do not contribute to the natural disease cycle.

Y. enterocolitica and Y. pseudotuberculosis cause yersiniosis, a diarrheal illness. The microbiological characteristics, pathogenic determinants and laboratory isolation and characterization of Y. enterocolitica and Y. pseudotuberculosis will be reviewed here. The epidemiology, clinical manifestations and treatment of these infections are discussed separately. (See "Epidemiology of yersiniosis" and "Clinical manifestations and diagnosis of Yersinia infections".)

Y. pestis causes plague and is discussed separately. (See "Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)" and "Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)".)

MICROBIOLOGY — Members of the genus Yersinia are gram-negative coccobacilli; they are facultative anaerobes in the family Yersiniaceae (formerly part of the family Enterobacteriaceae) [3,4]. Like others in the family, Y. pseudotuberculosis and Y. enterocolitica are bile tolerant and grow on MacConkey agar, they ferment glucose but not lactose, they are oxidase negative, and reduce nitrate to nitrite.

Y. pseudotuberculosis and Y. enterocolitica are readily differentiated by biochemical tests. Y. enterocolitica ferments sucrose and Y. pseudotuberculosis does not, while Y. pseudotuberculosis ferments rhamnose and melibiose and Y. enterocolitica does not. Y. enterocolitica can be further subtyped into biotypes by a combination of phenotypic markers [5]. They can also be serogrouped using antisera produced against cell surface lipopolysaccharide antigens, known classically as the O antigens [5,6]. For Y. enterocolitica, biogroup and serotype are correlated. The most common are serotype O:9 biotype 2, serotype O:3 biotype 4 and serotype O:8 biotype 1B [7]. A similar serotyping system exists for Y. pseudotuberculosis. Both Y. enterocolitica and Y. pseudotuberculosis can be further subtyped using molecular methods such as pulsed field gel electrophoresis or whole genome sequencing.

Y. enterocolitica exhibits three noteworthy microbiological features. It is psychrophilic, which means that on suitable media it is capable of multiplying at refrigerator temperatures (although its optimum growth temperature is 25 to 28°C). Second, most strains lack efficient intrinsic iron uptake mechanisms, and depend on the iron binding strategies of other bacteria to capture the iron that they need [8]. Conditions associated with iron-overload such as chronic liver disease, hemochromatosis, and thalassemias have been associated with an increased risk of invasive yersiniosis [9]. Third, many virulent strains are relatively calcium dependent, and require calcium-supplemented medium to grow at 37°C.

Certain subtypes of Y. enterocolitica are considered virulent for humans [10]. Isolation of non-virulent types from a non-sterile body site is likely to be an incidental finding. Rapid tests can determine whether an isolate is likely to be pathogenic (see below).

Subtyping by serotyping and/or molecular methods is of epidemiological utility. Biotype and serogroup can provide a clue to the environmental source of an infection [11]. Detecting a cluster of infections of the same molecular subtype may indicate that the cases are linked to a common source.

Laboratory isolation — Definitive laboratory identification of virulent strains depends on isolation of the organism via bacteriologic culture. Most laboratories in North America do not routinely screen for Yersinia species, and the organism grows poorly on the Salmonella-Shigella and Campylobacter agars commonly used for the isolation of stool pathogens [6]. Yersinia grows well on MacConkey agar, but at routine incubation temperatures it forms small colorless lactose-negative colonies, which are easily overlooked by the inexperienced eye unless plates are specifically examined for them [6].

Selective growth medium is recommended in laboratories not familiar with the appearance of the colonies. The most widely studied is cefsulodin-irgasin-novobiocin (CIN) agar, which inhibits the growth of competing flora and produces a characteristic colony morphology (figure 1) [12]. The optimal growth temperature for Yersinia species is 25 to 28°C, which also inhibits the growth of other organisms, even on non-selective MacConkey agar. The organism can be isolated at this temperature within 24 to 48 hours. If a clinician specifically requests Yersinia culture, the laboratory will usually either use CIN media or reincubate the original MacConkey agar culture. CHROMagar Yersinia is reported to be more selective for pathogenic strains of Y. enterocolitica, while Y. pseudotuberculosis does not grow on it at all [13].

The use of a cold enrichment step at 4°C can facilitate recovery of Y. enterocolitica when the bacterial density is low, such as in the convalescent phase of an infection. However, this procedure is likely to lead to isolation of non-pathogenic strains, and may require incubation for weeks, limiting clinical use. Isolates of Y. enterocolitica identified in this fashion must be further characterized before diagnostic conclusions are drawn.

The use of multi-pathogen syndromic diagnostic panels for fecal specimens has expanded. In 2018, 68 percent of yersiniosis cases reported to the United States Centers for Disease Control and Prevention (CDC) Foodborne Diseases Active Surveillance Network were diagnosed using such culture-independent panels; approximately half of those positive specimens that were cultured yielded a Yersinia [14]. The performance of panels that include a Y. enterocolitica target is difficult to measure because of the rarity of infection [15-17]. Just as with culture of cold-enriched specimens, characterization of the pathogen isolate obtained from reflex culture of the original specimen will still be helpful to determine whether it is pathogenic or not. Reflex culture of specimens that test positive by nucleic acid amplification tests (NAATs) is recommended to help guide treatment and for public health surveillance [18]. Multi-analyte panels typically do not include Y. pseudotuberculosis targets and will not detect that pathogen.

In addition to biotype and serotype determination, several rapid tests have been developed to identify pathogenic strains. They are highly specific and sensitive for fresh isolates, although the virulence plasmid can be lost when strains are stored [19]. The presence of pyrazinamidase also is strongly correlated with virulence, and is part of the Wauters biotype schema [5]. Use of Congo red-magnesium oxalate agar (CR-MOX) facilitates detection of the virulence plasmid capable of binding Congo Red dye, and calcium dependent growth at 37 degrees [20]. Polymerase chain reaction (PCR) assays for the presence of specific chromosomal and plasmid-associated virulence determinants have also been used [21].

Serologic assays have been described and used in some epidemiologic studies, but are of limited clinical utility due to crossreactivity [22].

PATHOGENESIS — Pathogenic Y. enterocolitica pass through the stomach, adhere to gut epithelial cells, invade the gut wall, localize in lymphoid tissue within the gut wall and in regional mesenteric lymph nodes, and evade the host's cell-mediated immune response. A 70 kilodalton virulence plasmid known as pYV has been associated with pathogenic Y. enterocolitica. Variants of this plasmid are also present in Y. pseudotuberculosis and Y. pestis, and the presence of the plasmid is closely correlated with calcium-dependency [23]. The organism’s capacity to produce urease releases ammonia from urea, which buffers local gastric acidity and provides relative acid resistance [24]. Adherence and invasion of the mucosal cells occurs via invasin and other surface proteins [25].

The organism elaborates additional proteins that allow it to evade host defense mechanisms, including phagocytosis and the bactericidal action of serum. Two such proteins, Ail (attachment invasion locus) and YadA, are adhesins that also confer resistance to complement-mediated opsonization. The most complex of these additional proteins are the Yersinia outer membrane proteins (Yops), which are encoded by a 70 kilodalton virulence plasmid [26]. The presence of this plasmid is an important virulence determinant, although some pathogenic strains that lack the virulence plasmid have been described.

The Yops are not simple outer membrane proteins, but an extraordinary array of effectors that are injected into host cells via a type III secretion system [27]. The injector apparatus is assembled at 37 degrees, and injection occurs on contact with the target cell. The injected Yops rapidly paralyze phagocytes, block secretion of recruitment molecules such as TNF-alpha and IL-8, and appear to inhibit activation of macrophages [27,28]. The cumulative effect is suppression of inflammation and evasion of phagocytosis.

Some Y. enterocolitica strains have genes for an iron-binding siderophore known as yersiniabactin, which can efficiently bind iron in iron deprived sites, permitting continued rapid growth of Y. enterocolitica biotype 1B [29]. Similar virulence mechanisms have been described in Y. pseudotuberculosis.

The expression of many of these virulence characteristics is temperature dependent [11]. At 25°C, the organism is motile and expresses urease and inv, while at 37°C the organism is non-motile but other virulence factors are expressed [30]. This temperature dependence may be important for survival of the organism outside of the host and for pathogenesis in the host.

A specific Yersinia heat-stable enterotoxin Yst has been described which is similar to the heat stable enterotoxin of enterotoxigenic E. coli [31,32]. Yst is secreted under temperature, pH, and osmolality conditions similar to that of the mammalian ileum [31,32].

A distinct strain of Y. pseudotuberculosis associated with the Far East Asia scarlet-like fever syndrome produces a superantigen, Y. pseudotuberculosis-derived mitogen A, that likely plays a role in the pathogenesis [33].

Y. enterocolitica biotype 1A has generally been regarded as avirulent, although some strains have been described that are clearly enteropathogenic even though they lack pYV and other known virulence determinants [10,34]. Therefore, it is likely that more virulence determinants remain to be identified.

Immunologic sequelae — The pathogenesis of reactive arthritis caused by Yersinia infection is likely to be related to an immune response to Yersinia antigens that cross-react with host antigens in susceptible individuals. The putative inciting Yersinia antigen has not been determined. Host tissue type appears to be the predominant co-factor; HLA-B27 is typically present [35]. T-cells derived from the joint fluid of patients with reactive arthritis have been reported to selectively kill HLA-B27–bearing cells that are also infected with Y. enterocolitica [36]. Although biotype 1A is usually regarded as avirulent, it may lead to reactive arthritis [37].

Erythema nodosum has also been reported in association with yersiniosis; it does not appear to be associated with HLA-B27 [38].

SUMMARY

Yersinia enterocolitica and Yersinia pseudotuberculosis cause yersiniosis, a diarrheal illness. Members of the genus Yersinia are gram-negative coccobacilli; they are facultative anaerobes in the family Enterobacteriaceae. (See 'Introduction' above.)

Y. enterocolitica exhibits three noteworthy microbiological features. It is capable of multiplying at refrigerator temperatures (although its optimum growth temperature is 25 to 28°C), many strains lack efficient intrinsic iron uptake mechanisms, and virulent strains require calcium-supplemented medium to grow at 37°C. (See 'Microbiology' above.)

Yersinia grows well on MacConkey agar, but at routine incubation temperatures it forms small colorless lactose-negative colonies, which are easily overlooked unless plates are specifically examined for them. Selective growth medium is recommended in laboratories not familiar with the appearance of the colonies. The most widely studied is cefsulodin-irgasin-novobiocin (CIN) agar, which inhibits the growth of competing flora and produces a characteristic colony morphology (figure 1). After initial isolation, additional characterization may be helpful as some Y. enterocolitica are likely to be non-pathogenic. (See 'Laboratory isolation' above.)

Rapid diagnosis of Y. enterocolitica infections is available on commercial multiplex polymerase chain reaction platforms, but these can detect avirulent as well as virulent strains. Culture and further characterization of isolates can assess virulence. (See 'Laboratory isolation' above.)

Pathogenic Y. enterocolitica pass through the stomach, adhere to gut epithelial cells, invade the gut wall, localize in lymphoid tissue within the gut wall and in regional mesenteric lymph nodes, and evade the host's cell-mediated immune response. They can evoke reactive immune phenomena, including reactive arthritis and erythema nodosum. (See 'Pathogenesis' above.)

REFERENCES

  1. Butler T. Plague and other Yersinia infections, Plenum Medical Books Co., New York 1983.
  2. McNally A, Thomson NR, Reuter S, Wren BW. 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution. Nat Rev Microbiol 2016; 14:177.
  3. Bottone EJ. Yersinia enterocolitica: Revisitation of an Enduring Human Pathogen. Clin Microbiol Newsletter 2015; 37:1.
  4. Adeolu M, Alnajar S, Naushad S, S Gupta R. Genome-based phylogeny and taxonomy of the 'Enterobacteriales': proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 2016; 66:5575.
  5. Wauters G, Kandolo K, Janssens M. Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol 1987; 9:14.
  6. Tsubokura M. Yersinioses other than plague. In: Laboratory Diagnosis of Infectious Diseases, Balows A, Hausler WJ Jr, Ohashi M, Turano A (Eds), Springer-Verlag, New York City 1989. p.540.
  7. Lobato MJ, Landeras E, González-Hevia MA, Mendoza MC. Genetic heterogeneity of clinical strains of Yersinia enterocolitica traced by ribotyping and relationships between ribotypes, serotypes, and biotypes. J Clin Microbiol 1998; 36:3297.
  8. Carniel E, Mazigh D, Mollaret HH. Expression of iron-regulated proteins in Yersinia species and their relation to virulence. Infect Immun 1987; 55:277.
  9. Cherchi GB, Cossellu S, Pacifico L, et al. Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients. Contrib Microbiol Immunol 1995; 13:16.
  10. Burnens AP, Frey A, Nicolet J. Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease. Epidemiol Infect 1996; 116:27.
  11. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10:257.
  12. Head CB, Whitty DA, Ratnam S. Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol 1982; 16:615.
  13. Renaud N, Lecci L, Courcol RJ, et al. CHROMagar Yersinia, a new chromogenic agar for screening of potentially pathogenic Yersinia enterocolitica isolates in stools. J Clin Microbiol 2013; 51:1184.
  14. Tack DM, Marder EP, Griffin PM, et al. Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015-2018. MMWR Morb Mortal Wkly Rep 2019; 68:369.
  15. Khare R, Espy MJ, Cebelinski E, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol 2014; 52:3667.
  16. Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 2015; 53:915.
  17. Simner PJ, Oethinger M, Stellrecht KA, et al. Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens. J Clin Microbiol 2017; 55:3258.
  18. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.
  19. Farmer JJ 3rd, Carter GP, Miller VL, et al. Pyrazinamidase, CR-MOX agar, salicin fermentation-esculin hydrolysis, and D-xylose fermentation for identifying pathogenic serotypes of Yersinia enterocolitica. J Clin Microbiol 1992; 30:2589.
  20. Riley G, Toma S. Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium. J Clin Microbiol 1989; 27:213.
  21. Feng P. Identification of invasive Yersinia species using oligonucleotide probes. Mol Cell Probes 1992; 6:291.
  22. Bottone EJ, Sheehan DJ. Yersinia enterocolitica: guidelines for serologic diagnosis of human infections. Rev Infect Dis 1983; 5:898.
  23. Cornelis GR, Boland A, Boyd AP, et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998; 62:1315.
  24. De Koning-Ward TF, Robins-Browne RM. Contribution of urease to acid tolerance in Yersinia enterocolitica. Infect Immun 1995; 63:3790.
  25. Carniel E. Chromosomal virulence factors of Yersinia: an update. Contrib Microbiol Immunol 1995; 13:218.
  26. Portnoy DA, Martinez RJ. Role of a plasmid in the pathogenicity of Yersinia species. Curr Top Microbiol Immunol 1985; 118:29.
  27. Cornelis GR. Yersinia type III secretion: send in the effectors. J Cell Biol 2002; 158:401.
  28. Boland A, Cornelis GR. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun 1998; 66:1878.
  29. Rakin A, Noelting C, Schubert S, Heesemann J. Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica. Infect Immun 1999; 67:5265.
  30. Badger JL, Miller VL. Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica. J Bacteriol 1998; 180:793.
  31. Takao T, Tominaga N, Yoshimura S, et al. Isolation, primary structure and synthesis of heat-stable enterotoxin produced by Yersinia enterocolitica. Eur J Biochem 1985; 152:199.
  32. Mikulskis AV, Delor I, Thi VH, Cornelis GR. Regulation of the Yersinia enterocolitica enterotoxin Yst gene. Influence of growth phase, temperature, osmolarity, pH and bacterial host factors. Mol Microbiol 1994; 14:905.
  33. Amphlett A. Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A. Open Forum Infect Dis 2016; 3:ofv202.
  34. Morris JG Jr, Prado V, Ferreccio C, et al. Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors. J Clin Microbiol 1991; 29:2784.
  35. Aho K, Ahvonen P, Lassus A, et al. HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974; 17:521.
  36. Hermann E, Yu DT, Meyer zum Büschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342:646.
  37. Tuompo R, Hannu T, Huovinen E, et al. Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis. Rheumatol Int 2017; 37:1863.
  38. Laitinen O, Leirisalo M, Skylv G. Relation between HLA-B27 and clinical features in patients with yersinia arthritis. Arthritis Rheum 1977; 20:1121.
Topic 3134 Version 12.0

References

1 : Butler T. Plague and other Yersinia infections, Plenum Medical Books Co., New York 1983.

2 : 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution.

3 : Yersinia enterocolitica: Revisitation of an Enduring Human Pathogen

4 : Genome-based phylogeny and taxonomy of the 'Enterobacteriales': proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov.

5 : Revised biogrouping scheme of Yersinia enterocolitica.

6 : Revised biogrouping scheme of Yersinia enterocolitica.

7 : Genetic heterogeneity of clinical strains of Yersinia enterocolitica traced by ribotyping and relationships between ribotypes, serotypes, and biotypes.

8 : Expression of iron-regulated proteins in Yersinia species and their relation to virulence.

9 : Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients.

10 : Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease.

11 : Yersinia enterocolitica: the charisma continues.

12 : Comparative study of selective media for recovery of Yersinia enterocolitica.

13 : CHROMagar Yersinia, a new chromogenic agar for screening of potentially pathogenic Yersinia enterocolitica isolates in stools.

14 : Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015-2018.

15 : Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens.

16 : Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.

17 : Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens.

18 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

19 : Pyrazinamidase, CR-MOX agar, salicin fermentation-esculin hydrolysis, and D-xylose fermentation for identifying pathogenic serotypes of Yersinia enterocolitica.

20 : Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium.

21 : Identification of invasive Yersinia species using oligonucleotide probes.

22 : Yersinia enterocolitica: guidelines for serologic diagnosis of human infections.

23 : The virulence plasmid of Yersinia, an antihost genome.

24 : Contribution of urease to acid tolerance in Yersinia enterocolitica.

25 : Chromosomal virulence factors of Yersinia: an update.

26 : Role of a plasmid in the pathogenicity of Yersinia species.

27 : Yersinia type III secretion: send in the effectors.

28 : Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.

29 : Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica.

30 : Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica.

31 : Isolation, primary structure and synthesis of heat-stable enterotoxin produced by Yersinia enterocolitica.

32 : Regulation of the Yersinia enterocolitica enterotoxin Yst gene. Influence of growth phase, temperature, osmolarity, pH and bacterial host factors.

33 : Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A.

34 : Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors.

35 : HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

36 : HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

37 : Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

38 : Relation between HLA-B27 and clinical features in patients with yersinia arthritis.